LA Jolla Pharma (LJPC)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
6.22 unch (unch) 08/19/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 6.22 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 19,660 | -39,421 | -116,508 | -199,469 | -114,803 |
| Depreciation Amortization | 1,881 | 4,084 | 5,859 | 4,405 | 1,268 |
| Accounts receivable | -2,776 | -1,687 | -1,579 | -1,381 | N/A |
| Accounts payable and accrued liabilities | -484 | -2,815 | -4,395 | -2,912 | 4,832 |
| Other Working Capital | -5,031 | -17,059 | -6,833 | 512 | 6,460 |
| Other Operating Activity | 14,994 | 19,258 | 38,506 | 46,477 | 17,162 |
| Operating Cash Flow | $28,244 | $-37,640 | $-84,950 | $-152,368 | $-85,081 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | N/A | -698 | -2,340 | -9,194 |
| Net Acquisitions | N/A | -33,513 | N/A | N/A | N/A |
| Purchase Of Investment | 0 | -2,999 | 0 | N/A | N/A |
| Sale Of Investment | 0 | 2,497 | 0 | N/A | N/A |
| Purchase Sale Intangibles | 0 | 3,070 | 0 | N/A | N/A |
| Other Investing Activity | 0 | 3,070 | 0 | 0 | 0 |
| Investing Cash Flow | $-9 | $-30,945 | $-698 | $-2,340 | $-9,194 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 592 | 1,117 | 864 | 112,108 | 120,173 |
| Common Stock Repurchased | -3,380 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 124,289 | 0 |
| Financing Cash Flow | $-2,788 | $1,117 | $864 | $236,397 | $120,173 |
| Beginning Cash Position | 21,261 | 88,729 | 173,513 | 91,824 | 65,926 |
| End Cash Position | 46,708 | 21,261 | 88,729 | 173,513 | 91,824 |
| Net Cash Flow | $25,447 | $-67,468 | $-84,784 | $81,689 | $25,898 |
| Free Cash Flow | |||||
| Operating Cash Flow | 28,244 | -37,640 | -84,950 | -152,368 | -85,081 |
| Capital Expenditure | -9 | 0 | -698 | -2,340 | -9,194 |
| Free Cash Flow | 28,235 | -37,640 | -85,648 | -154,708 | -94,275 |